Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10526629 RNA polymerase variants

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 5, 2019
Date of Patent
January 7, 2020
Patent Application Number
16432541
Patent Citations
‌
US Patent 10273269 High potency immunogenic zika virus compositions
‌
US Patent 10207010 Compositions and methods for delivery of agents
‌
US Patent 10064934 Combination PIV3/hMPV RNA vaccines
‌
US Patent 10034951 Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity
‌
US Patent 10064935 Human cytomegalovirus RNA vaccines
‌
US Patent 10124055 Zika virus RNA vaccines
‌
US Patent 10144942 Modification of RNA-related enzymes for enhanced production
Patent Citations Received
‌
US Patent 12133899 Coronavirus vaccine
0
‌
US Patent 11484590 Human cytomegalovirus RNA vaccines
‌
US Patent 11485960 RNA polymerase variants for co-transcriptional capping
‌
US Patent 11497807 Zoonotic disease RNA vaccines
‌
US Patent 12090235 Preparation of lipid nanoparticles and methods of administration thereof
0
‌
US Patent 12128113 Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
0
‌
US Patent 11464848 Respiratory syncytial virus vaccine
‌
US Patent 11235052 Chikungunya virus RNA vaccines
‌
US Patent 11541113 Human cytomegalovirus vaccine
‌
US Patent 10695419 Human cytomegalovirus vaccine
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10526629
Patent Primary Examiner
‌
Maryam Monshipouri

Find more entities like US Patent 10526629 RNA polymerase variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo